Cargando...
Mechanisms of Resistance to Immune Checkpoint Blockade
The recent development of effective immune checkpoint inhibition (ICI), first demonstrated in melanoma, has revolutionized cancer treatment. Monoclonal antibodies blocking the immune checkpoints cytotoxic T-lymphocyte associated antigen 4 (CTLA-4) and programmed death 1 receptor (PD-1) have shown su...
Gardado en:
| Publicado en: | Am J Clin Dermatol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6358473/ https://ncbi.nlm.nih.gov/pubmed/30259383 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40257-018-0389-y |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|